ADIA Nutrition Inc. Requests SIC Code Update to 2836 (Biological Products) with SEC and OTC Markets

Core Perspective - ADIA Nutrition Inc. is updating its SIC code to better reflect its focus on biological products, moving from 2834 (Pharmaceutical Preparations) to 2836 (Biological Products, Except Diagnostic) [1][3] Company Operations - The company specializes in regenerative medicine, particularly in the manufacturing and distribution of proprietary biologics [1][7] - ADIA operates through its lab division, Adia Labs LLC, which sells FDA-registered products like AdiaVita and AdiaLink [6][7] - The company is expanding its network of Adia Med clinics that provide specialized regenerative treatments, including stem cell therapy and advanced biologics [6][7] Financial Performance - ADIA reported over 200% revenue growth in Q3 2025, indicating strong business momentum [3] - Revenue streams include service fees, product sales, equity stakes, and insurance billing for healthcare treatments [8] Strategic Partnerships - The company is open to strategic partnerships with clinic owners and healthcare practitioners to expand access to its regenerative therapies [4][8] - ADIA invests in aligned businesses, such as Cement Factory LLC, to enhance its health and wellness focus [8]